Clinical Trials Using Ondansetron
Clinical trials are research studies that involve people. The clinical trials on this list are studying Ondansetron. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Aprepitant or Fosaprepitant in Combination with Dexamethasone and Ondansetron in Preventing Nausea and Vomiting in Patients with Cancer Receiving Carboplatin-Based Chemotherapy
This phase II trial studies how well aprepitant or fosaprepitant in combination with dexamethasone and ondansetron work in preventing nausea and vomiting in patients with cancer receiving carboplatin-based chemotherapy. Giving aprepitant or fosaprepitant in addition to standard anti-nausea medications such as dexamethasone and ondansetron may help control nausea and vomiting better compared to in dexamethasone and ondansetron alone in patients receiving carboplatin-based chemotherapy.
Location: Montefiore Medical Center-Weiler Hospital, Bronx, New York
Rolapitant Hydrochloride in Preventing Nausea / Vomiting in Patients with Sarcoma Receiving Chemotherapy
This randomized phase II trial studies how well rolapitant hydrochloride works in preventing nausea / vomiting in patients with sarcoma receiving chemotherapy. Antiemetic drugs, such as rolapitant hydrochloride, may help control or prevent nausea and vomiting in patients treated with chemotherapy.
Location: M D Anderson Cancer Center, Houston, Texas
Rolapitant Hydrochloride and Ondansetron versus Ondansetron Monotherapy in Evaluating Efficacy, Patient Satisfaction, and Compliance in Patients with Malignant Glioma Undergoing Chemotherapy and Radiation Therapy
This randomized phase II trial studies rolapitant hydrochloride and ondansetron versus ondansetron monotherapy in evaluating efficacy, patient satisfaction, and compliance in patients with malignant glioma undergoing chemotherapy and radiation therapy. Antiemetic drugs, such as rolapitant hydrochloride and ondansetron, may help lessen or prevent nausea and vomiting in patients treated with chemotherapy and radiation therapy.
Location: Duke University Medical Center, Durham, North Carolina